Community Health Azithromycin Trial in Burkina Faso (CHAT)
Sponsor: Bill and Melinda Gates Foundation
This PHASE4 trial investigates Childhood Mortality and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 17 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
17 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Mar 2023 — Jan 2024 [monthly]
Recruiting PHASE4
▶ Show 12 earlier versions
-
Nov 2022 — Mar 2023 [monthly]
Recruiting PHASE4
-
Nov 2021 — Nov 2022 [monthly]
Recruiting PHASE4
-
Feb 2021 — Nov 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE4
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Sep 2019 — Jan 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE4
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE4
-
Mar 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2018 — Mar 2019 [monthly]
Not Yet Recruiting PHASE4
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bill and Melinda Gates Foundation
- Centre de Recherche en Sante de Nouna, Burkina Faso
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .